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Infrastructure never gets adequately funded because it cuts 
across disciplinary boundaries, it doesn’t benefit particular 
groups.  Infrastructure is a prerequisite to great leaps forward 
and is thus never captured within disciplinary funding, or 
normal governmental operations.  We need to revise radically 
our conception of cyberinfrastructure.  It isn’t just a set of 
tubes through which bytes flow, it is a set of structures that 
network different areas of knowledge … and that is software 
and social engineering, not fiber optic cable.  The 
superhighways of the biological information age should not 
be understood as simply physical data roads, long ropes of 
fiber and glass.  They need to be structures of knowledge.  
The Eisenhower Freeways of Biological Knowledge are yet to 
be built.  But that doesn’t mean the task isn’t worth starting. 
– James Boyle, William Neal Reynolds Professor of Law,   
Duke University Law School 
KNOWLEDGE SHARING AND SCHOLARLY 
PROGRESS 
Knowledge sharing is at the root of scholarship and science.  A 
hypothesis is formulated, research performed, experimental materials 
designed or acquired, tests run, data obtained and analysed, and finally a 
publication.  The scholar writes a document outlining the work for 
dissemination in a scholarly journal.  
                                                        
1 Executive Director of Science Commons.  This chapter was first published as an  article in 
(2007) 3 (3) CTWatch Quarterly <http://www.ctwatch.org/quarterly/articles/2007/08/ 
cyberinfrastructure-for-knowledge-sharing/>. 
Cyberinfrastructure for Knowledge Sharing 241
If it passes the litmus test of peer review, the research enters the canon 
of the discipline.  Over time, it may become a classic with hundreds of 
citations.  Or, more likely, it will join the vast majority of research, with 
less than two citations over its lifetime, its asserted contributions to the 
canon increasingly difficult to find – because, in our current world, 
citations are the best measure of relevance-based search available. 
But no matter the fate of an individual publication, the system of 
publishing is a system of sharing knowledge.  We publish as scholars and 
scientists to share our discoveries with the world (and, of course, to be 
credited with those discoveries through additional research funding, 
tenure, and more).  And this system has served science extraordinarily 
well over the more than three hundred years since scholarly journals 
were birthed in France and England. 
THE INFORMATION TECHNOLOGY REVOLUTION: 
MISSED CONNECTIONS AND LOST OPPORTUNITIES 
Into this old and venerable system has come the earthquake of modern 
information and communication technologies.  The Internet and the 
Web have made publication cheap and sharing easy – from a technical 
perspective.  The cost of moving, copying, forwarding, and storing the 
bits in a single scientific publication approach zero.  
These technologies have created both enormous efficiency gains in 
traditional industries (think about how Wal-Mart uses the network to 
optimise its supply chains) and radical reformulation of industry 
(Amazon.com in books, or iTunes in music).  Yet the promise of 
enormous increases in efficiency and radical reformulations have to date 
failed to make similar shattering changes to the rate of meaningful 
discovery in many scientific disciplines.  
For the purposes of this article, I focus on the life sciences in particular.  
The problems I articulate affect all the scientific disciplines to one extent 
or another – but the life sciences represent an ideal discussion case.  The 
life sciences are endlessly complex and the problems of global health and 
pharmaceutical productivity such an enormous burden that the pain of a 
missed connection is personal.  Climate change represents a problem of 
similar complexity and import to the world, and this article should be 
contemplated as bearing on research there as well, but my topic is in the 
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application of cyberinfrastructure to the life sciences, and there I’ll try to 
remain.  
Despite new technology after new technology, the cost of discovering a 
drug keeps increasing, and the return on investment in life sciences (as 
measured by new drugs hitting the market for new diseases) keeps 
dropping.  While the Web and email pervade pharmaceutical companies, 
the elusive goal remains ‘knowledge management’: finding some way to 
bring sanity to the sprawling mass of figures, emails, data sets, databases, 
slide shows, spreadsheets, and sequences that underpin advanced life 
sciences research.  Bioinformatics, combinatorial drug discovery, 
systems biology, and an innumerable number of words ending with ‘-
omics’ have yet to relieve the skyrocketing costs and increase the 
percentage of success in clinical trials for new drug compounds. 
The reasons for this are many.  First and foremost, drug discovery is 
hard – really, really hard.  And much of the low-hanging fruit has been 
picked.  There are other reasons having to do with regulatory 
requirements, scientific competition, distortions in funding, and more.  
But there is one reason that stands out as both a significant drag on 
discovery and as a treatable problem, one that actually can be solved in 
the short term: we aren’t sharing knowledge as efficiently as we could be.  
FORGET ‘WEB 2.0’ – WHAT ABOUT ‘WEB 1.0’ FOR 
SCIENCE? 
Much of the functionality we take for granted on the Web comes from 
making the choice to make sharing information easier, not harder.  A 
good example is the way that Google interacts with the scientific 
literature.  
With few exceptions, we rank the importance and relevance of scientific 
articles the way we always have, with citations and ‘impact factors’.  
Citations are longstanding and important.  Impact factors – the number 
of citations to the articles in a journal – are the dominant metric for 
journal quality.  And for a long time, citations were clearly the best, and 
perhaps the only, statistical measure of quality of a journal.  In a print 
world, a world without hyperlinks and search engines and blogs and 
collaborative filtering, citations are a beacon of relevance.  
But we live in a different world now.  We have the ability to make 
connection after connection between documents, to traverse easily from 
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one page to another page.  Hyperlinks are cheap and they’re everywhere.  
It was a conscious design decision made by Tim Berners-Lee to allow 
this functionality.  Other competing systems thought it insane that the 
WWW would let just anyone link to just anything else – those links 
might be broken, leading to the dreaded ‘404 not found’ – and that 
would obviously kill the WWW!  It hasn’t worked out that way.  The 
choice to allow users the right to make hyperlinks, to make hyperlinking 
easy and fast, not only did not kill the Web, it is a big part of what makes 
Google searching so powerful. 
Google ranks pages by downloading enormous chunks of the Web and 
running software that analyses the linkages between Web pages.  The 
system quite literally depends on there being lots and lots of links, many 
of them perhaps useless on their own, but which in aggregate provide 
hints of relevance.  Thus, the number one Google search on the words 
‘Science Commons’ is the Web page analysed with the words ‘Science 
Commons’ that has the most links pointing to it.  There’s more 
complexity, obviously, but that’s a big part of the idea. 
If those Web pages were private, the page ranking system wouldn’t 
work.  The Web pages themselves are part of the infrastructure on 
which Google operates, on which millions of start-up dreams are 
founded.  In a world where every page was locked, where every Web 
designer had to ask permission to make an inbound link … we wouldn’t 
have the sprawling value creation we associate with the Internet.  It 
would look a lot more like Prodigy looked a long time ago: a closed 
network that can’t compete in the end with the open networks. 
Put another way, we have far more efficiency brought to bear on 
accelerating our capability to order consumer products than we do on 
accelerating our capability to perform scientific research.  Biological 
reagents and assays are re-invented and reverse-engineered by readers of 
‘papers’ – years of laboratory work, data, living DNA and more 
compressed down to the digital equivalent of a sheet of dead tree.  
We need the Web to work as well for science as it does for other areas.  
The capabilities now exist to integrate information, data, physical tools, 
order fulfilment, overnight shipping, online billing, one-to-one orders, 
and more.  If we are to solve the persistent health problems of the 
world, of infectious disease in the developing world and rare disease in 
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the developed world, the ‘Web 1.0’ efficiency is an obvious benefit to 
bring to the life sciences.  
But these advances we take for granted in daily life, like Google’s 
relevance based search of the entire Web, eBay’s many-to-many listing 
and fulfilment, Amazon’s one-click ordering, won’t come to science 
accidentally.  There’s a significant collective action problem blocking the 
adoption of these systems and preventing the network effects from 
taking over in discovery.  
But it’s not just the Google issue, which simply forces us to forego 
existing technology and focus on citations as we have always done.  
Citations carry more constrictions as a search metaphor.  You are likely 
to enter the citation search ranked world when you know what to search.  
But you might not know what you’re looking for.  You might not know 
how to say it in the nomenclature of a related, but distinct, discipline.  
It goes on.  Citation linkages between papers are subject to enormous 
social pressures.  One cites the papers of one’s bosses, of course.  
Review articles can skew impact factors.  And of course, a tried-and-true 
way to get a heavily cited article remains to be horrifically, memorably 
wrong. 
And over the long term, the lack of more complex and realistic 
interconnections between articles – a web, a set of highways, an 
infrastructure connecting the knowledge – is that we can’t begin to 
integrate the articles with the databases.  That’s because the actors in the 
articles (the genes, proteins, cells and diseases) are described in hundreds 
of databases.  
And if we could link the articles not just to each other by a richer 
method than citations, but to the databases, we can inch closer to the 
goal of a Rosetta Stone of knowledge, the small element upon which we 
can begin to have truly integrated, public knowledge spaces.  That would 
in turn allow us to begin automatically indexing the data that robots are 
producing in labs every day, to meaningfully extract actionable 
information from the terabytes of genomic data we are capable of 
producing. 
You get those virtues only where you are dealing with the knowledge 
claims themselves, not the sub-component of them the people in the 
field thought it worthy to expose.  Only a better infrastructure gets you 
there, just as the modern highway system in the US allowed for better 
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efficiency than the evolved hodge-podge of state highways.  Citation 
linkages are very useful (and a later version needs to cross reference 
them with these highways we propose – we didn’t throw away the state 
highways, after all!).  This is simply a different set of tasks, and one that 
can be accomplished if enough smart people have enough rights and 
time to work on the knowledge.  
But sadly, no one – no one! – has the right to download and index with 
scholarly literature without burning years of time and money in 
negotiations.  Google has spent years asking for the right to index a lot 
of the scholarly canon for its Scholar project, but that’s not some open 
land trust for any researcher to work on.  It’s just for Google.  And the 
fact that Google alone has the right to index articles for such a service 
means that the next Google, the next set of genius entrepreneurs with a 
taste for search coding away in the halls of the local university, can’t 
apply their skills to the sciences. 
Though we have the capability to drastically increase the sharing at a 
much lower cost through digital distribution, search, and more, the 
reaction has been instead to segregate knowledge behind walls of cost, 
technology, and competitive secrecy.  The net result is that we’re doing 
things the way we always did, but only somewhat faster.  If we want to 
bring both efficiency gains and radical transformation to the life 
sciences, getting more knowledge online, with the rights to transform, 
twist, tag, reformat, translate, and more, is going to be part of the 
solution.  We have to start allowing the best minds of the world to apply 
the newest technologies to the scientific problems facing us. 
There isn’t a single, open ‘Web’ of content to search – it’s owned by a 
group of publishers who prevent indexing and search outside their own 
engines, and who use copyright and contracts to keep it locked up.  
There isn’t any easy way to find the tools of biological science – it’s a 
complicated social system of call-and-response, of email and phone calls, 
of ‘are you in the club of scientists worth partnering with?’ questions and 
answers.  And there isn’t a standard way to get your orders fulfilled, but 
instead a system in itself of materials transfer and ordering, university 
technology transfer, commercial incentives, deliberate withholding, and 
more.  We don’t have the Web working yet for science. 
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INFRASTRUCTURE FOR KNOWLEDGE SHARING: 
SCIENCE COMMONS 
I work on a project called Science Commons – part of the Creative 
Commons (CC) non-profit organisation (CC is the creator of a set of 
legal tools for sharing copyrighted works on the Web using a modular 
set of machine-readable contracts.  CC licenses cover more the  
150 million copyrighted objects on the Web, including such high-impact 
offerings as BioMed Central, Public Library of Science, Nature 
Precedings, Hindawi Publishing, and the UniProt database of proteins.  
Science Commons is building a toolkit of policy, contracts, and 
technology that increases the chance of meaningful discovery through a 
shared, open approach to scientific research.  We’re building part of the 
infrastructure for knowledge sharing, and we’re also deploying some test 
cases to demonstrate the power of investing in this kind of 
infrastructure. 
Science Commons isn’t alone.  Sharing approaches that address a single 
piece of the research cycle are making real, but painfully slow, progress.  
Open Access journals are far from the standard.  Biological research 
materials are still hard to find and harder to access.  And while most data 
remains behind the firewall at laboratories, even those data sets that do 
make it online are frequently poorly annotated and hard to use.  The 
existing approaches are not creating the radical acceleration of scientific 
advancement that is made possible by the technical infrastructure to 
generate and share information.  
Science Commons represents an integrated approach – one with 
potential to create this radical acceleration.  We are targeting three key 
blocking points in the scientific research cycle – access to the literature, 
experimental materials, and data sharing – in a unified approach.  We are 
testing the hypothesis that the solutions to one problem represent inputs 
to the next problem, and that a holistic approach to the problems 
discussed here potentially benefits from network effects and can create 
disruptive change in the throughput of scientific research.  I will outline 
how these approaches represent tentative steps towards open knowledge 
infrastructure in the field of neuroscience. 
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KNOWLEDGE OVERLOAD FOR HUNTINGTON’S 
DISEASE 
Figure 1. Biological pathway for Huntington’s Disease. 
 
Source: Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, 
M., Katayama, T., Kawashima, S., Okuda, S., Tokimatsu, T., and Yamanishi, 
Y., “KEGG for linking genomes to life and the environment.” Nucleic Acids. 
Res. 36, D480–D484 (2008).  
Above is the biological pathway for Huntington’s Disease.  This pathway 
is like a circuit – it governs the movement of information between genes 
and proteins, processes and locations in the cell.  This one is a relatively 
simple pathway, as far as such things go.  More complex pathways can 
have hundreds of elements in the network, each ‘directional’ - not just 
linked like Web pages, but typed and directed links, where the kind of 
relationship and the causal order are vital both in vitro and in silico.  
In this pathway, the problem is the HD gene in the middle of the circuit 
- if that gene is broken, it leads to a cascade that causes a rare, fatal 
disease where the brain degenerates rapidly.  Although the genetic 
element has been understood for a long time, there is no cure.  Not 
enough people get the disease for it to be financially worth finding a 
cure, given how expensive it is to find drugs and get them to market.  
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That’s cold comfort to the tens of thousands of people who succumb 
each year and to their families who know they have a 50% chance of 
passing on the gene and disease to their children.  But that’s the reality.  
Years of research have led to an enormous amount of knowledge about 
Huntington’s.  For example, a search in the U.S. government’s free 
Entrez web resource on ‘Huntington’s’ yields more than 6000 papers, 
450+ gene sequences, 200+ protein sequences, and 55 000 expression 
and molecular abundance profiles.  That’s a lot of knowledge.  The 
papers alone would take 17 years to read, at the rate of one paper per 
day (and that’s assuming no new papers are published in the intervening 
years).  Yet Huntington’s actually provides a relatively small result.  One 
of the actors in the pathway is called ‘TP53’.  That brings up another 
2500 papers, but also brings up (in an indirect link to a page about 
sequences for this entity) that it has a synonym: ‘p53’.  Entrez brings 
back 42 000 articles from that search string – 115 years to read!  
It goes on and on.  And having all of this knowledge is wonderful.  But 
there are more than a few problems here.  The first is something you 
might call ‘cognitive overload’.  Our brains simply aren’t strong enough 
to take in 500 000 papers, read them all, build a mental model of the 
information, and then use that information to make decisions - decisions 
like, what happens if I knock out that CASP box in the pathway, with  
27 000 papers?  
The other problems stem from the complexity of the body.  In what 
other circuits is each entity in the pathway involved?  What about those 
tricky causal relationships above and below it in the circuit?  What are 
the implications of intervention in this circuit on the other circuits?  
Some of these entities, the boxes in the diagram, are metaphorically 
similar to the airport in Knoxville, TN.  Knocking out that airport 
doesn’t foul up a lot of air traffic.  But some of these - P53 for example - 
are more like Chicago.  Interfering with that piece of the network 
reverberates across a lot of unrelated pieces of the network.  That’s what 
we call side effects, and it’s one of the reasons drugs are so expensive - 
we know that we can impact this circuit, but we don’t realise how badly 
it affects everything else until we run the drug in the only model 
available that covers all possible impacts: the human body.  
And this is just the papers.  There are thousands of databases with 
valuable information in them.  Each of them has different access 
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privilege conditions, different formats, different languages, and different 
goals; wasn’t designed to work with anything else; and is maintained at 
different levels of quality.  But they have vital - or potentially vital, to the 
right person asking the right question - information.  And if we could 
connect the knowledge around these knowledge sources into a single 
network we just might be able to leverage the power of other 
technologies built for other networks.  (Like Google – but maybe more 
like the next Google, something as dramatically better and different and 
radical as Google was when we first saw it in the late 1990s.) 
There are two problems to be addressed here.  One is the materials that 
underpin this knowledge, these databases and articles.  Those materials 
are ‘dark’ to the Web, invisible, and not subject to the efficiency gains we 
take for granted in the consumer world.  The second is the massive 
knowledge overload that the average scientist faces.  I’ll outline two 
proofs of concept to demonstrate the value of investment in 
infrastructure for knowledge sharing that can address these problems. 
PROOF OF CONCEPT: E-COMMERCE FOR 
BIOLOGICAL MATERIALS 
The Biological Materials Transfer Agreement Project (MTA) develops 
and deploys standard, modular contracts to lower the costs of 
transferring physical biological materials such as DNA, cell lines, model 
animals, antibodies and more.  Materials represent tacit knowledge – 
generating a DNA plasmid or an antibody can take months or years, and 
replicating the work is rarely feasible.  Gaining access to those materials 
is subject to secrecy, competition, lack of resources to manufacture 
materials, lack of time, legal transaction costs and delays, and more.  
There is significant evidence that the transfer of biological materials is 
subject to significant slowdowns.  Campbell2 and Cohen3 have each 
demonstrated that materials are frequently denied.  Legal barriers are 
part of the problem – more so than patents – but the greater problem is 
frequently the competition, secrecy, and incentive systems involved.  
                                                        
2 See Eric Campbell and David Blumenthal, ‘The Selfish Gene: Data Sharing and Withholding 
in Academic Genetics’, Science, 31 May 2002  
3 See Wesley Cohen et al, Where Excludability Matters: Material v. Intellectual Property in Academic 
Biomedical Research <http://siepr.stanford.edu/programs/SST_ 
Seminars/walsh.pdf>, which illustrates the benefits of self-archiving. 
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This is why we brought in funders of disease research and institutional 
hosts of research from the beginning – this is the part of infrastructure 
that is social engineering, not software.  The secrecy and competition do 
not maximise the likelihood of meaningful discovery coming from 
limited funding, and thus funders (especially of rare or orphan diseases) 
have a particular incentive to maximise the easy movement of biological 
materials to maximise follow-on research. 
The MTA project covers transfers among non-profit institutions as well 
as between non-profit and for-profit institutions.  It integrates existing 
standard agreements into a Web-deployed suite alongside new Science 
Commons contracts and allows for the emergence of a transaction 
system along the lines of Amazon or eBay by using the contracts as a 
tagging and discovery mechanism for materials.  
This metadata driven approach is based on the success of the Creative 
Commons licensing integration into search engines and further allows 
for the integration of materials licensing directly into the research 
literature and databases so that scientists can ‘one-click’ inline as they 
perform typical research.  And like Creative Commons licensing, we can 
leverage the existing Web technologies to track materials propagation 
and reuse, creating new data points for the impact of scientific research 
that are more dimensional than simple citation indices, tying specific 
materials to related peer-reviewed articles and data sets. 
The MTA project was launched in collaboration with the Kauffman 
Foundation, the iBridge Network of university technology transfer 
offices, and neurodegenerative disease funders.  It currently includes 
more than 5000 DNA plasmids covered under standard contracts and is 
available through the Neurocommons project described in the next 
section. 
PROOF OF CONCEPT IN KNOWLEDGE SHARING: A 
SEMANTIC WEB FOR NEUROSCIENCE 
In collaboration with the W3C Semantic Web Health Care and Life 
Science interest group, we are integrating information from a variety of 
standard sources to establish core interoperable content that can be used 
as a basis for bioinformatics applications.  The combined whole is 
greater than the sum of its parts, since queries can cut across 
combinations of sources in arbitrary ways.  
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We are also providing an operational knowledge base that has a 
standard, open query endpoint accessible by Internet.  The knowledge 
base incorporates information marshalled from more than a dozen 
databases, ontologies, and literature sources.  
Entities discussed in the text, such as proteins and diseases, need to be 
specifically identified for computational use, as do the entities’ 
relationships to the text and the text’s assertions about the entities (for 
example, a particular asserted relationship between a protein and a 
disease).  Manual annotation by an author, editor, or other ‘curator’ may 
capture the text’s meaning accurately in a formal notation.  However, 
automated natural language processing (including entity extraction and 
text mining) is likely to be the only practical method for opening up the 
literature for computational use. 
We were only able to process the abstracts of the literature as the vast 
majority of the scientific literature is locked behind firewalls and under 
contracts that explicitly prevent using software to automatically index 
the full text where it is accessible.  Although most papers run more than 
five pages, the abstracts typically were limited to a paragraph.  
For tractability, we limited the scope to the organisms of greatest interest 
to health care and life sciences research: human, mouse, and rat.  We are 
also providing the opportunity for interested parties to ‘mirror’ the 
knowledgebase and we encourage its wide reuse and distribution. 
In combination with the data integration and text processing, we are also 
offering a set of analytic tools for use on experimental data.  The 
application of prior knowledge to experimental data can lead to fresh 
insights.  For example, a set of genes or proteins derived from high 
throughput experiments can be statistically scored against sets of related 
entities derived from the literature.  Particular sets that score well may 
indicate what’s going on in the experimental setting. 
In order to help illustrate the value of semantic web practices, we are 
developing statistical applications that exploit information extracted 
from RDF data sources, including both conversions of structured 
information (such as Gene Ontology annotations) and relationships 
extracted from literature.  The first tools we hope to roll out are activity 
centre analysis for gene array data and set scoring for profiling of 
arbitrary gene sets, donated to Science Commons by Millennium 
Pharmaceuticals. 
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Taken together, we call these three efforts the Neurocommons – an 
open source, open access knowledge management platform, with an 
initial therapeutic focus on the neurosciences.  And we hope to use the 
Neurocommons both as a platform to facilitate knowledge sharing and 
to secure empirical evidence as to the value of shared knowledge in 
sciences.  
CONCLUSION: CYBERINFRASTRUCTURE FOR 
KNOWLEDGE SHARING 
The Neurocommons project is a very good start.  It shows the potential 
of shared knowledge systems built on open content.  And it has the 
potential to explode through horizontal downloading, editing, and 
reposting, as the Web exploded.  The idea of connectivity via ‘viewing 
source’ is an explicit part of our design methodology, and our tools have 
already been picked up and integrated into such systems as the Mouse 
BIRN Atlasing Toolkit (MBAT), which was built from the combined 
efforts of groups within the Mouse BIRN (Biomedical Informatics 
Research Network, a distributed network of researchers with more than 
$25 million in U.S. Government funding). 
But the Neurocommons is, at root, a proof of concept.  And from it we 
are learning some basic lessons about the need for infrastructure for 
knowledge sharing.  Science Commons is on a daily basis forced to 
create namespaces, persistent URLs, and line after line of ‘plumbing 
code’ to wire together knowledge sources.  
If we are going to get to the goal stated above, of dramatic increases in 
efficiency and radical transformation of outmoded discovery models, we 
are going to need a lot of infrastructure that doesn’t yet exist.  
We need publishers to look for business models that aren’t based on 
locking up the full text, because the contents of the journals – the 
knowledge – is itself part of the infrastructure, and closed infrastructure 
doesn’t yield network effects.  We need open, stable namespaces for 
scientific entities that we can use in programming and integrating 
databases on the open Web, because stable names are part of the 
infrastructure.  We need real solutions about long-term preservation of 
data (long-term meaning a hundred years or more).  We need new 
browsers and better text processing.  We need a sense of what it means 
to ‘publish’ in a truly digital sense, in place of the digitisation of the 
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paper metaphor we have in the PDF format.  We need infrastructure 
that makes it easy to share and integrate knowledge, not just publish it 
on the Web.  
None of this is easy. Much of it is very, very hard.  But the current 
system is simply not working.  And the reward of pulling together what 
we already know into open view, in open formats, where geniuses can 
process and exploit it, could be a world in which it is faster, easier, and 
cheaper to find drugs and cure disease.  This is possible.  We just have to 
have the vision and courage to build the highways. 
 
